Get the Stockscreener App
48.93
1.30%
+0.63
Overview
News
Price History
Option Chain
Why BMY Down?
Discussions
Forecast
Stock Split
Dividend History
Bristol-Myers Squibb Co. Stock (BMY) Forecast
The Bristol-Myers Squibb Co. (BMY) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $55.73, representing a +13.90% increase from the current price of $48.93. The highest analyst price target is $68.66, and the lowest is $42.80.
Based on our technical indicators, the current sentiment is bearish but BMY could still hit $68.66 in 2025. This might not be a good time to consider opening new positions on BMY, as trading bearish markets can be challenging and may result in losses.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BMY Price Target
Average 55.73
(+13.90% Upside)
Bristol-Myers Squibb Co. Stock (BMY) Technical Analysis Forecast
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.15 | Neutral |
| STOCH(9,6) | 10.81 | Buy |
| STOCHRSI(14) | 39.31 | Neutral |
| MACD(12,26) | -0.9646 | Sell |
| ADX(14) | 27.70 | Sell |
| William %R | -77.07 | Neutral |
| CCI(14) | -60.54 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
49.22
Sell
|
49.24
Sell
|
| MA20 |
50.85
Sell
|
50.16
Sell
|
| MA50 |
51.12
Sell
|
50.86
Sell
|
| MA100 |
50.76
Sell
|
51.75
Sell
|
| MA200 |
54.49
Sell
|
55.09
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
Long-term BMY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Our analysts are offering long term price forecasts for Bristol-Myers Squibb Co. In 2050, the median target price for BMY is $79.06, with a high estimate of $82.78 and a low estimate of $62.80. The median estimate represents a +61.57% increase from the last price of $48.93. Below is our long term BMY Price forecast table with detailed price target for each year.
| Year | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| 2024 | $58.97 | $42.80 | $59.50 | +20.51% |
| 2025 | $59.04 | $46.08 | $68.66 | +20.66% |
| 2026 | $65.93 | $57.07 | $70.07 | +34.75% |
| 2027 | $75.98 | $53.54 | $80.91 | +55.29% |
| 2028 | $65.98 | $63.39 | $81.76 | +34.85% |
| 2029 | $46.15 | $44.94 | $66.78 | -5.69% |
| 2030 | $54.00 | $43.12 | $68.98 | +10.36% |
| 2035 | $48.42 | $43.44 | $59.92 | -1.05% |
| 2040 | $49.27 | $45.58 | $72.03 | 0.70% |
| 2045 | $67.45 | $64.36 | $82.72 | +37.84% |
| 2050 | $79.06 | $62.80 | $82.78 | +61.57% |
Bristol-Myers Squibb Co. Stock (BMY) Year by Year Forecast
Bristol-Myers Squibb Co. Stock (BMY) Price Forecast for 2024
For Bristol-Myers Squibb Co. Stock (BMY) price forecast for 2024, the average price target for Bristol-Myers Squibb Co. Stock is $51.15 with a high forecast of $59.50 and a low forecast of $42.80. The average BMY price prediction of 2024 represents a +4.53% increase from the last price of $48.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $48.94 | $44.93 | $50.13 | +0.01% |
| June, 2024 | $45.54 | $45.18 | $48.47 | -6.94% |
| July, 2024 | $46.20 | $44.86 | $49.87 | -5.58% |
| August, 2024 | $44.81 | $42.80 | $46.99 | -8.42% |
| September, 2024 | $48.28 | $44.83 | $49.46 | -1.34% |
| October, 2024 | $50.47 | $47.58 | $51.38 | +3.14% |
| November, 2024 | $53.40 | $48.87 | $53.49 | +9.13% |
| December, 2024 | $58.97 | $52.88 | $59.50 | +20.51% |
Bristol-Myers Squibb Co. Stock (BMY) Price Forecast for 2025
Bristol-Myers Squibb Co. Stock (BMY) is expected to reach an average price of $57.37 in 2025, with a high prediction of $68.66 and a low estimate of $46.08. This indicates an +17.25% rise from the last recorded price of $48.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $64.34 | $55.62 | $65.07 | +31.49% |
| February, 2025 | $63.21 | $62.87 | $64.87 | +29.19% |
| March, 2025 | $67.42 | $62.83 | $68.66 | +37.79% |
| April, 2025 | $60.28 | $56.70 | $67.87 | +23.19% |
| May, 2025 | $55.93 | $46.08 | $59.46 | +14.31% |
| June, 2025 | $61.43 | $53.84 | $63.50 | +25.55% |
| July, 2025 | $61.11 | $60.00 | $65.66 | +24.89% |
| August, 2025 | $56.67 | $54.39 | $62.49 | +15.82% |
| September, 2025 | $60.70 | $56.24 | $61.00 | +24.06% |
| October, 2025 | $63.48 | $57.67 | $64.59 | +29.74% |
| November, 2025 | $60.27 | $59.57 | $64.40 | +23.18% |
| December, 2025 | $59.04 | $57.22 | $61.26 | +20.66% |
Bristol-Myers Squibb Co. Stock (BMY) Price Forecast for 2026
The 2026 price forecast for Bristol-Myers Squibb Co. Stock (BMY) stands at an average of $63.57. Projections range from a high of $70.07 to a low of $57.07, signifying an +29.93% increase from the previous price of $48.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $58.77 | $57.07 | $62.74 | +20.11% |
| February, 2026 | $63.37 | $59.16 | $66.55 | +29.51% |
| March, 2026 | $61.47 | $60.24 | $64.06 | +25.63% |
| April, 2026 | $64.88 | $60.79 | $67.48 | +32.60% |
| May, 2026 | $60.92 | $59.69 | $65.97 | +24.51% |
| June, 2026 | $64.26 | $58.95 | $64.30 | +31.33% |
| July, 2026 | $65.77 | $62.00 | $65.96 | +34.42% |
| August, 2026 | $67.37 | $61.83 | $68.24 | +37.69% |
| September, 2026 | $66.79 | $63.54 | $68.28 | +36.50% |
| October, 2026 | $67.48 | $65.56 | $67.89 | +37.91% |
| November, 2026 | $67.83 | $66.10 | $69.66 | +38.63% |
| December, 2026 | $65.93 | $65.61 | $70.07 | +34.75% |
Bristol-Myers Squibb Co. Stock (BMY) Price Forecast for 2027
For 2027, the average price target for Bristol-Myers Squibb Co. Stock (BMY) is $67.23, with a high forecast of $80.91 and a low forecast of $53.54. This indicates an +37.39% increase from the last price of $48.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $59.48 | $59.47 | $65.88 | +21.56% |
| February, 2027 | $57.91 | $56.98 | $60.35 | +18.36% |
| March, 2027 | $56.85 | $56.14 | $60.52 | +16.19% |
| April, 2027 | $61.88 | $53.54 | $62.99 | +26.47% |
| May, 2027 | $63.86 | $61.18 | $66.17 | +30.52% |
| June, 2027 | $67.20 | $61.51 | $67.68 | +37.34% |
| July, 2027 | $69.68 | $66.14 | $69.97 | +42.41% |
| August, 2027 | $74.14 | $67.65 | $74.39 | +51.53% |
| September, 2027 | $75.59 | $73.67 | $78.49 | +54.49% |
| October, 2027 | $76.46 | $74.53 | $78.94 | +56.27% |
| November, 2027 | $79.28 | $72.03 | $79.32 | +62.03% |
| December, 2027 | $75.98 | $73.56 | $80.91 | +55.29% |
Bristol-Myers Squibb Co. Stock (BMY) Price Forecast for 2028
Bristol-Myers Squibb Co. Stock (BMY) is estimated to achieve an average price of $72.57 in 2028, with a high projection of $81.76 and a low estimate of $63.39. This suggests an +48.32% rise from the preceding price of $48.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $75.65 | $72.03 | $76.12 | +54.61% |
| February, 2028 | $70.48 | $66.27 | $76.18 | +44.05% |
| March, 2028 | $70.02 | $69.52 | $76.31 | +43.11% |
| April, 2028 | $77.79 | $68.65 | $78.98 | +58.99% |
| May, 2028 | $80.60 | $74.88 | $81.49 | +64.73% |
| June, 2028 | $73.21 | $72.63 | $81.76 | +49.63% |
| July, 2028 | $72.77 | $71.07 | $75.32 | +48.73% |
| August, 2028 | $71.43 | $70.12 | $75.50 | +45.99% |
| September, 2028 | $66.03 | $65.75 | $72.30 | +34.95% |
| October, 2028 | $70.77 | $65.60 | $71.39 | +44.64% |
| November, 2028 | $68.38 | $66.34 | $71.26 | +39.75% |
| December, 2028 | $65.98 | $63.39 | $68.78 | +34.85% |
Bristol-Myers Squibb Co. Stock (BMY) Price Forecast for 2029
The 2029 price forecast for Bristol-Myers Squibb Co. Stock (BMY) is $55.86 on average, with a high prediction of $66.78 and a low estimate of $44.94. This represents an +14.16% increase from the previous price of $48.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $62.97 | $62.95 | $66.78 | +28.70% |
| February, 2029 | $62.51 | $60.37 | $65.70 | +27.76% |
| March, 2029 | $62.40 | $60.03 | $63.04 | +27.53% |
| April, 2029 | $59.22 | $58.65 | $63.73 | +21.03% |
| May, 2029 | $56.78 | $56.02 | $59.60 | +16.05% |
| June, 2029 | $50.93 | $49.81 | $57.09 | +4.09% |
| July, 2029 | $50.63 | $48.57 | $52.06 | +3.48% |
| August, 2029 | $52.62 | $48.53 | $52.86 | +7.54% |
| September, 2029 | $49.57 | $44.94 | $53.48 | +1.31% |
| October, 2029 | $51.62 | $48.52 | $53.44 | +5.50% |
| November, 2029 | $50.60 | $49.43 | $55.02 | +3.41% |
| December, 2029 | $46.15 | $45.67 | $50.75 | -5.69% |
Bristol-Myers Squibb Co. Stock (BMY) Price Forecast for 2030
Bristol-Myers Squibb Co. Stock (BMY) is expected to reach an average price of $56.05 in 2030, with a high forecast of $68.98 and a low forecast of $43.12. This signifies an +14.55% surge from the last price of $48.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $47.67 | $45.25 | $50.45 | -2.57% |
| February, 2030 | $47.45 | $45.50 | $48.46 | -3.03% |
| March, 2030 | $46.52 | $45.18 | $50.19 | -4.92% |
| April, 2030 | $46.64 | $43.12 | $47.31 | -4.69% |
| May, 2030 | $48.60 | $45.60 | $49.78 | -0.68% |
| June, 2030 | $50.79 | $47.90 | $51.70 | +3.79% |
| July, 2030 | $55.75 | $49.19 | $58.01 | +13.93% |
| August, 2030 | $59.29 | $55.35 | $59.82 | +21.16% |
| September, 2030 | $64.03 | $55.94 | $65.39 | +30.86% |
| October, 2030 | $65.79 | $63.19 | $66.61 | +34.45% |
| November, 2030 | $67.74 | $63.15 | $68.98 | +38.44% |
| December, 2030 | $54.00 | $51.26 | $68.19 | +10.36% |
0.91%
Cap:
|
Volume (24h):